RPS6KB1 and lung carcinoma: The fact that mTORC1 activation is also found in a subgroup of patients with malignancies, such as gastric cancer or lung cancer, together with our observation that 32% of the patients with HP and vasculitis show S6K activation, supports the hypothesis that mTORC1 is probably not universally active in different diseases.